ghk-cu kpv GHK-Cu, BPC-157, TB-500, GHK-Cu | True Peptides

Based on the February 2026 HHS announcement and analysis from compounding pharmacy and regulatory experts, the peptides expected to return to Category 1 status include BPC-157, Thymosin Alpha-1, TB-500, CJC-1295, Ipamorelin, AOD-9604, GHK-Cu, Selank, Semax, KPV, MOTS-C, and several others approximately 14 of the original 19 restricted compounds

Some users combine both peptides in single injections for convenience

I highly recommend it to anyone in Australia looking for effective relief. Mark R., Sydney, NSW Living in rural Victoria, access to specialized treatments can sometimes be a challenge

Galvani CA, Loebl H, Osuchukwu O, Samam J, Apel ME, Ghaderi I

The peptide prevents both excessive proteolysis that impairs healing and insufficient matrix turnover that creates rigid, dysfunctional scar tissue